Real Answers.
MARSHALL, Mich. — Oaklawn is pleased to announce the appointment of David A. Swender, D.O., as Chief Medical Officer (CMO), effective September 1, 2026. Dr. Swender, a board-certified allergist and immunologist, has served the Marshall community through Oaklawn Medical Group... Read More: Oaklawn Names Dr. David Swender Chief Medical Officer, Retains Allergy, Asthma & Immunology Services
MARSHALL, Mich. — The Oaklawn Board of Directors has announced that Dr. J. Summer Liston-Crandall, MD, MBA, FACHE, has been appointed President and Chief Executive Officer of Oaklawn, effective September 1, 2026. Dr. Liston-Crandall will succeed Gregg Beeg, who will... Read More: Oaklawn Announces Planned Leadership Transition; Dr. Summer Liston-Crandall Named Next President & CEO
Lymphedema is a condition that affects millions of people and can significantly impact daily life if left untreated. Understanding the signs, risk factors, and available treatments can help you take action early and manage symptoms effectively. What is Lymphedema? Lymphedema... Read More: Understanding Lymphedema: Causes, Symptoms, and Treatment Options
